Results 231 to 240 of about 283,009 (351)

Quantitation of adenosine-5'-triphosphate used for phosphoinositide metabolism in human erythrocytes [PDF]

, 1985
GL Dale
openalex   +1 more source

Increasing the succinate yield in Actinobacillus succinogenes by fumigation of H2 in a bioreactor

Biofuels, Bioproducts and Biorefining, EarlyView.
Abstract The microbial conversion of CO2 into value‐added chemicals offers a promising and scalable route for sustainable bioproduction, particularly under mild reaction conditions and with technically straightforward reactor configurations. Actinobacillus succinogenes, a natural succinate producer, can fix CO2 through anaplerotic carboxylation but its
Julian Tix, Gustav Zimpel, Roland Ulber, Nils Tippkötter   +3 more
wiley   +1 more source

Evaluation of efficacy of SmartLite Pro EndoActivator sonic activation using adenosine triphosphate bioluminescence meter: A randomized clinical trial. [PDF]

J Conserv Dent Endod
Basam RC, Bolla N, Cross R, Vemuri S, Bolla L, Vajrala NR.   +5 more
europepmc   +1 more source

Nitrogenase of Klebsiella pneumoniae. Inhibition of acetylene reduction by magnesium ion explained by the formation of an inactive dimagnesium–adenosine triphosphate complex [PDF]

, 1974
R. N. F. Thorneley, Keith R. Willison
openalex   +1 more source

Effect of developmental changes on pharmacokinetics of drugs used in the treatment of infant acute lymphoblastic leukaemia—A comprehensive review

British Journal of Clinical Pharmacology, EarlyView.
While the event‐free survival (EFS) of children treated for acute lymphoblastic leukaemia (ALL) has improved greatly in the last decades, the EFS for patients diagnosed with ALL before the age of one is still under 50%. This outcome further decreases when infants have a rearrangement in the gene encoding histone‐lysine N‐methyltransferase 2A (KMT2A ...
Tirsa de Kluis, Leiah J. Brigitha, Lidwien M. Hanff, Alwin D. R. Huitema, Inge M. van der Sluis, Meta H. M. Diekstra   +5 more
wiley   +1 more source

Protective effect of adenosine triphosphate against cisplatin-induced necrotic and degenerative oral mucositis in rats. [PDF]

J Appl Oral Sci
Salcan I, Dilber M, Suleyman Z, Yucel N, Salcan S, Kesan S, Yazici GN, Celik F, Koseturk M, Alcan Alp N, Suleyman H.   +10 more
europepmc   +1 more source

Population pharmacokinetics of TBAJ‐587 and its main metabolites—Evaluation of different loading dose strategies and early dose selection

British Journal of Clinical Pharmacology, EarlyView.
Background and Aim The rise of drug‐resistant tuberculosis (TB) poses a need for new drugs and combinations. TBAJ‐587, a new diarylquinoline (DARQ), has shown promising efficacy in preclinical studies. This work aimed to describe the pharmacokinetics (PK) of TBAJ‐587 and its metabolites M2 and M3 after single ascending dosing in healthy volunteers and ...
Albin A. M. Leding, Paul Bruinenberg, Almari Conradie, Jerry Nedelman, Antonio Lombardi, Dean Hickman, Ulrika S. H. Simonsson   +6 more
wiley   +1 more source

Inhibitory Effects of Aquadag, a Black Carbon Surrogate, on Microbial Growth via Surface-Mediated Stress: Evidence from Adenosine Triphosphate Assay. [PDF]

Toxics
Yoo H, Lim S, Cho IS, Im H, Lee E, Choi S, Kim HS, Jeong S, Choi Y.   +8 more
europepmc   +1 more source

Effects of Renal and Hepatic Impairment on the Pharmacokinetics of Zilurgisertib

British Journal of Clinical Pharmacology, EarlyView.
Aim Small‐molecule activin receptor‐like kinase‐2 inhibitor zilurgisertib (INCB000928) is under investigation in a pivotal trial for the treatment of fibrodysplasia ossificans progressiva (FOP), an ultrarare genetic condition. This analysis assessed effects of renal and hepatic impairment on zilurgisertib pharmacokinetics.
Yan‐ou Yang, Yunlan Fang, Phillip Wang, Xiang Liu, Jay Getsy, Kevin Rockich   +5 more
wiley   +1 more source

Effects of adenosine triphosphate, thiamine pyrophosphate, melatonin, and liv-52 on subacute pyrazinamide proliferation hepatotoxicity in rats. [PDF]

BMC Pharmacol Toxicol
Ciftel S, Ciftel S, Altuner D, Huseynova G, Yucel N, Mendil AS, Sarigul C, Suleyman H, Bulut S.   +8 more
europepmc   +1 more source